Bortezomib API

Get a Price/Quote

Bortezomib API Specification

Storage
Dry Place

Melting Point
139-143

Molecular Formula
C19H25BN4O4

Solubility
The solubility of bortezomib, as the monomeric boronic acid, is 3.3 to 3.8 mg/mL in a pH range of 2 to 6.5

Shelf Life
5 Years

Boiling point
305.1

Medicine Name
Bortezomib

Chemical Name
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid

CAS No
179324-69-7

Usage
Antineoplastic

Appearance
white or almost white powder

Physical Form
Powder

Bortezomib API Trade Information

FOB Port
ALL INDIA

Payment Terms
Telegraphic Transfer (T/T), Western Union, Paypal, Cash in Advance (CID), Cash Advance (CA)

Delivery Time
2-3 Week

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.

Main Export Market(s)
Western Europe, Australia, North America, Eastern Europe, Middle East, Central America, South America, Asia, Africa

Main Domestic Market
All India

Certifications
WHO,GMP,COA,MSDS As Per Client Requirement

About Bortezomib API

Bortezomib is used for treating relapsed multiple myeloma and mantle cell lymphoma.

Bortezomib interferes with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be affected by bortezomib, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as a skin rash, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.

Product: Bortezomib
CAS NO.: 179324-69-7
M.F.: C19H25BN4O4
M.W.: 384.2372
Appearance: white or almost white powder
Usage: to treat multiple myeloma

Packaging details:

Packaging details:	25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Storage:	Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat
Shelf Life:	5 years if sealed and store away from direct sun light.

Key Product Features

Bortezomib is available in powder form and appears as a white or nearly white powder. It boasts a shelf life of five years and must be stored in a dry place to ensure stability. The product complies with international standards, making it suitable for pharmaceutical manufacturing. Its melting and boiling points are 139-143C and 305.1C, respectively.

Usage and Benefits

Bortezomib API is primarily used as an antineoplastic agent in chemotherapy for certain cancers. Its targeted action helps inhibit the growth of cancer cells, making it a critical component in the treatment of multiple myeloma and other malignancies. The product's purity and stability ensure optimal performance in formulation and clinical settings.

Why Choose Us as Your Partner?

We are a trusted manufacturer, supplier, and exporter of Bortezomib API from India, serving pharmaceutical companies worldwide. Our stringent quality controls and timely delivery set us apart in the industry. By sourcing from us, clients receive consistently high-quality products that meet global regulatory requirements.

FAQ's of Bortezomib API:

Q: How should Bortezomib API be stored for maximum shelf life?

A: Bortezomib API should be stored in a dry place at controlled room temperature to preserve its stability. Keeping the powder away from moisture and extreme conditions helps maintain its five-year shelf life.

Q: What is the process for handling and using Bortezomib API in pharmaceutical manufacturing?

A: The API is supplied as a white or almost white powder and should be weighed and solubilized following standard pharmaceutical protocols. Its solubility is 3.3-3.8 mg/mL within a pH range of 2 to 6.5, allowing it to be incorporated into various formulations for chemotherapy treatments.

Q: When is Bortezomib API typically used in medicine?

A: Bortezomib API is used in the formulation of antineoplastic drugs, specifically for cancer therapies such as multiple myeloma. Its inclusion in treatment regimens is determined by oncologists according to patient need and therapy protocols.

Q: Where do you supply and export Bortezomib API from?

A: We are based in India and distribute, export, manufacture, supply, and trade Bortezomib API to pharmaceutical companies worldwide, complying with global quality standards.

Q: What are the main benefits of incorporating Bortezomib API in cancer treatment formulations?

A: Utilizing Bortezomib API offers targeted anti-cancer activity, contributing to the effectiveness of chemotherapy drugs with a focus on inhibiting cancer cell growth. Its high purity and reliable quality also support consistent therapeutic results.

Q: Is Bortezomib API compatible with various pharmaceutical formulations?

A: Yes, due to its favorable solubility profile (3.3-3.8 mg/mL in pH 2-6.5) and stable powder form, Bortezomib API is suitable for diverse pharmaceutical formulations that require accurate dosing and reliable performance.

Tell us about your requirement